Preliminary observations on expression of transforming growth factors β1 and β3 in equine full-thickness skin wounds healing normally or with exuberant granulation tissue

Veterinary Surgery

Volumn 31, Issue 3, 2002, Pages 266-273

  Theoret, Christine L ^a,c   Barber, Spencer M ^a   Moyana, Terence N ^b   Gordon, John R ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL; ANIMAL DISEASE; ARTICLE; BANDAGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GRANULATION TISSUE; HORSE; INJURY; LIMB; METABOLISM; RANDOMIZED CONTROLLED TRIAL; SKIN; TIME; WOUND HEALING;

ANIMALS; BANDAGES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTREMITIES; GRANULATION TISSUE; HORSES; SKIN; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; WOUND HEALING; WOUNDS AND INJURIES;

EID: 0036584959     PISSN: 01613499     EISSN: 1532950X     Source Type: Journal    
DOI: 10.1053/jvet.2002.32394     Document Type: Article

References (45)

1. Bertone AL: Second intention healing. Vet Clin North Am: Equine Pract 5:539-550, 1989
2. Jacobs KA, Leach DH, Fretz PB, et al: Comparative aspects of the healing of excisional wounds on the leg and body of horses. Vet Surg 13:83-90, 1984
3. O'Kane S, Ferguson MWJ: Transforming growth factor βs and wound healing. Int J Biochem Cell Biol 29:63-78, 1997
4. Theoret CL: Growth factors in cutaneous wound repair. Compend Contin Educ Pract Vet 23:383-391, 2001
5. Roberts AB, Sporn MB: Transforming growth factor-β, in Clark RAF (ed): The Molecular and Cellular Biology of Wound Repair (ed 2). New York, NY, Plenum Press, 1996, pp 275-308
6. Frank S, Madlener M, Werner S: Transforming growth factors β1, β2, and β3 and their receptors are differentially regulated during normal and impaired wound healing. J Biol Chem 271:10188-10193, 1996
7. Shah M, Foreman DM, Ferguson MWJ: Neutralisation of TGF-β1 and TGF-β2 or exogenous addition of TGF-β3 to cutaneous rat wounds reduces scarring. J Cell Sci 108:985-1002, 1995
8. Adzick NS, Lorenz HP: Cells, matrix, growth factors and the surgeon. The biology of scarless fetal wound repair. Ann Surg 220:10-18, 1994
9. Whitby DJ, Ferguson MWJ: Immunolocalization of growth factors in fetal wound healing. Dev Biol 147:2207-2215, 1991
10. Shah M, Foreman DM, Ferguson MWJ: Neutralising antibody to TGF-β1,2 reduces cutaneous scarring in adult rodents. J Cell Sci 107:1137-1157, 1994
11. Choi BM, Kwak HJ, Jun CD, et al: Control of scarring in adult wounds using antisense transforming growth factor-β1 oligodeoxynucleotides. Immunol Cell Biol 74:144-150, 1996
12. Meager DM, Adams OR: Skin transplantation in horses. Can Vet J 11:239-248, 1970
13. McCauley RL, Chopra V, Li Y, et al: Altered cytokine production in black patients with keloids. J Clin Immunol 12:300-308, 1992
14. Park RW, Lee BH, Kim IS, et al: Collagen synthesis in fibroblasts from keloid lesions and their responses to transforming growth factor-beta. Korean J Biochem 27:209-217, 1995
15. Peltonen J, Hsiao LL, Jaakola S, et al: Activation of collagen gene expression in keloids: Colocalization of type I and type VI collagen and TGF-β1 mRNA. J Invest Dermatol 97:240-248, 1991
16. Lee TY, Chin GS, Kim WJ, et al: Expression of TGF-β1, 2 and 3 proteins in keloids. Ann Plast Surg 43:179-184, 1999
17. Fretz PB, Martin GS, Jacobs KA, et al: Treatment of exuberant granulation tissue in the horse: Evaluation of four methods. Vet Surg 12:137-140, 1983
18. Bertone AL, Sullins KE, Stashak TS, et al: Effect of wound location and the use of topical collagen gel on exuberant granulation tissue formation and wound healing in the horse and pony. Am J Vet Res 46:1438-1444, 1985
19. Barber SM: Second intention wound healing in the horse: The effect of bandages and topical corticosteroids. Proc Am Assoc Equine Practnr 35:107-116, 1990
20. Bigbie RB, Schumacher J, Moll D, et al: Equine amnion as a biological dressing in the treatment of open wounds in horses. Proc Am Assoc Equine Practnr 35:117-125, 1989
21. Bigbie RB, Schumacher J, Swaim SF, et al: Effects of amnion and live yeast cell derivative on second-intention healing in horses. Am J Vet Res 52:1376-1382, 1991
22. Blackford JT, Blackford LW, Adair HS: The use of an antimicrobial glucocorticosteroid ointment on granulating lower leg wounds in horses. Proc Am Assoc Equine Practnr 37:71-81, 1991
23. Madison JB, Hamir AN, Ehrlich HP, et al: Effects of a proprietary topical medication on wound healing and colla-gen deposition in horses. Am J Vet Res 52:1128-1131, 1991
24. Howard RD, Stashak TS, Baxter GM: Evaluation of occlusive dressings for management of full-thickness excisional wounds on the distal portion of the limbs of horses. Am J Vet Res 54:2150-2154, 1993
25. Wilson DA, Adelstein EH, Keegan KG, et al: In vitro and in vivo effects of activated macrophage supernatant on distal limb wounds of ponies. Am J Vet Res 57:1220-1224, 1996
26. Theorel CL, Barber SM, Moyana TN, et al: Expression of transforming growth factor beta-1, beta-3, and basic fibroblast growth factor in full-thickness skin wounds of equine limbs and thorax. Vet Surg 30:269-277, 2001
27. Gordon JR, Galli SJ: Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the FceRI. Role for mast cell-derived transforming growth factor-beta and tumor necrosis factor-alpha. J Exp Med 180:2027-2037, 1995
28. Caswell JL, Middleton DM, Sorden SD, et al: Expression of the neutrophil chemoattractant interleukin-8 in the lesions of bovine pneumonic pasteurellosis. Vet Pathol 35:124-131, 1997
29. Theoret CL, Barber SM, Gordon JR: The expression of IL-1, IL-6, and TGF-β in the synovial fluid of horses with surgically-induced transient synovitis. Vet Comp Orthop Traumatol 11:141-145, 1999
30. Penha-Goncalves MN, Onions DE, Nicolson L: Cloning and sequencing of equine transforming growth factor-beta-1 (TGF-β1) cDNA. DNA Seq 7:375-378, 1997
31. Barral-Netto M, Barral A, Brownell CE, et al: Transforming growth factor-beta in leishmanial infection: A parasite escape mechanism. Science 257:545-548, 1992
32. Schultz-Cherry S, Murphy-Ulrich JE: Thrombospondin causes activation of latent TGF-β secreted by endothelial cells by a novel mechanism. J Cell Biol 122:923-932, 1993
33. Cochrane CA: Models in vivo of wound healing in the horse and the role of growth factors. Vet Dermatol 8:259-272, 1997
34. Wilminck JM, Van Weeren PR, Stolk PW, et al: Differences in second-intention wound healing between horses and ponies: Histological aspects. Equine Vet J 31:61-67, 1999
35. Kane CJ, Habda PA, Mansbridge JN, et al: Direct evidence for spatial and temporal regulation of TGF-β1 expression during cutaneous wound healing. J Cell Physiol 148:157-173, 1991
36. Messadi DV, Berg S, Sung CK, et al: Autocrine TGF-β1 activity and glycosaminoglycan synthesis by human cutaneous scar fibroblasts. Wound Repair Regen 2:284-291, 1994
37. Sullivan KM, Lorenz HP, Meuli M, et al: A model of scarless human fetal wound repair is deficient in TGF-β. J Pediatr Surg 30:198-203, 1995
38. Shah M, Foreman DM, Ferguson MWJ: Control of scarring in adult wounds by neutralising antibody to transforming growth factor β. Lancet 339:213-214, 1992
39. Polo M, Smith PD, Kim YJ, et al: Effects of TGF-β2 on proliferative scar fibroblast cell kinetics. Ann Plast Surg 43:185-190, 1999
40. Steel CM, Robertson ID, Thomas J, et al: Effect of topical rh-TGF-β1 on second intention wound healing in horses. Aust Vet J 77:734-737, 1999
41. Sempowski GD, Borrello MA, Blieden TM, et al: Fibroblast heterogeneity in the healing wound. Wound Repair Regen 3:120-313, 1995
42. Garner WL, Karmiol S, Rodriguez JL, et al: Phenotypic differences in cytokine responsiveness of hypertrophic scar versus normal dermal fibroblasts. J Invest Dermatol 101:875-879, 1993
43. Hakkinen L, Westermarck J, Kahari VM, et al: Human granulation tissue fibroblasts show enhanced proteoglycan gene expression and altered response to TGF-β1. J Dent Res 75:1767-1778, 1996
44. Falanga V, Julien JM: Observations in the potential role of TGF-β in cutaneous fibrosis. Systemic sclerosis. Ann NY Acad Sci 593:161-171, 1990
45. Schmid P, Itin P, Cherry G, et al: Enhanced expression of TGF-β and type II receptors in wound granulation tissue and hypertrophic scar. Am J Pathol 152:485-493, 1998